Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-27 @ 2:39 AM
Study NCT ID:
NCT04358393
Status:
RECRUITING
Last Update Posted:
2024-02-01
First Post:
2020-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS
Sponsor:
Ascentage Pharma Group Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-04
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-04-21
First Submit QC Date:
None
Study First Post Date:
2020-04-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-30
Last Update Post Date:
2024-02-01
Last Update Post Date Type:
ACTUAL